MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $111,000 | +246.9% | 43,800 | +200.0% | 0.00% | – |
Q4 2019 | $32,000 | -98.0% | 14,600 | -96.5% | 0.00% | -100.0% |
Q2 2018 | $1,606,000 | 0.0% | 420,400 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $1,606,000 | -67.8% | 420,400 | -31.3% | 0.00% | -66.7% |
Q4 2017 | $4,991,000 | +179.9% | 611,677 | +101.4% | 0.01% | +200.0% |
Q3 2017 | $1,783,000 | – | 303,777 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |